Document is current
Any future updates will be listed below
-
Authors
Berg-Hansen, Kristoffer
Gopalasingam, Nigopan
Pedersen, Mette Glavind Bülow
Nyvad, Jakob Tobias
Rittig, Nikolaj
Søndergaard, Esben
Wiggers, Henrik
Møller, Niels
Nielsen, Roni
-
Funding
Funding for this research was provided by:
Danmarks Frie Forskningsfond (8020-00120A)
Novo Nordisk Fonden (NNF17OC0028230, NNF19OC0055002)
Lundbeck Foundation (R231-2016-2716)
Hjerteforeningen (19-R135-A9280-22126)
- License Information
-
More Information
Article History
Received: 2 November 2024
Accepted: 6 January 2025
First Online: 17 January 2025
Competing interests
: Roni Nielsen has collaboration with the pharceutical companies Imbria, Medtrace, Resother as an investigation and has received lectural fee from Astrazeneca. Roni Nielsen is a patentholder of 20205938.2 A Lactate/Ketone Body ester, 5-11-2020. Henrik Wiggers has been the principal or a sub-investigator in studies involving the following pharmaceutical companies: MSD, Bayer, Daiichi-Sankyo, Novartis, Novo Nordisk, Sanofi-Aventis, and Pfizer.
